These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2568168

  • 1. Heterogeneous expression of erbB-2 messenger RNA in human breast cancer.
    King CR, Swain SM, Porter L, Steinberg SM, Lippman ME, Gelmann EP.
    Cancer Res; 1989 Aug 01; 49(15):4185-91. PubMed ID: 2568168
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M, Barrois M, Terrier MJ, Spielmann M, Riou G.
    Oncogene Res; 1988 Aug 01; 3(1):21-31. PubMed ID: 2905033
    [Abstract] [Full Text] [Related]

  • 3. High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2.
    Henry JL, Coggin DL, King CR.
    Cancer Res; 1993 Mar 15; 53(6):1403-8. PubMed ID: 8095182
    [Abstract] [Full Text] [Related]

  • 4. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas.
    Walker RA, Senior PV, Jones JL, Critchley DR, Varley JM.
    J Pathol; 1989 Jun 15; 158(2):97-105. PubMed ID: 2569035
    [Abstract] [Full Text] [Related]

  • 5. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.
    Shiga K, Shiga C, Sasano H, Miyazaki S, Yamamoto T, Yamamoto M, Hayashi N, Nishihira T, Mori S.
    Anticancer Res; 1993 Jun 15; 13(5A):1293-301. PubMed ID: 7902061
    [Abstract] [Full Text] [Related]

  • 6. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I, Dietrich PY, Aapro M, Vauthier G, Vadas L, Engel E.
    Cancer Res; 1989 Dec 01; 49(23):6675-9. PubMed ID: 2573420
    [Abstract] [Full Text] [Related]

  • 7. Increased erbB-2 gene copies and expression in multiple stages of breast cancer.
    Iglehart JD, Kraus MH, Langton BC, Huper G, Kerns BJ, Marks JR.
    Cancer Res; 1990 Oct 15; 50(20):6701-7. PubMed ID: 2208136
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. c-erbB-2 amplification in node-negative human breast cancer.
    Ro JS, el-Naggar A, Ro JY, Blick M, Frye D, Fraschini G, Fritsche H, Hortobagyi G.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6941-4. PubMed ID: 2573424
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.
    Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, Hynes NE.
    Cancer Res; 1988 Mar 01; 48(5):1238-43. PubMed ID: 2893663
    [Abstract] [Full Text] [Related]

  • 14. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG, Ethier SP.
    Cell Growth Differ; 1996 May 01; 7(5):551-61. PubMed ID: 8732665
    [Abstract] [Full Text] [Related]

  • 15. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
    Dawkins HJ, Robbins PD, Smith KL, Sarna M, Harvey JM, Sterrett GF, Papadimitriou JM.
    Pathol Res Pract; 1993 Dec 01; 189(10):1233-52. PubMed ID: 7910395
    [Abstract] [Full Text] [Related]

  • 16. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ, Frierson HF, Williams ME.
    Mod Pathol; 1993 Nov 01; 6(6):654-9. PubMed ID: 7905628
    [Abstract] [Full Text] [Related]

  • 17. Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancer.
    Kerns BJ, Jordan PA, Huper G, Marks JR, Iglehart JD, Layfied LJ.
    Mod Pathol; 1993 Nov 01; 6(6):673-8. PubMed ID: 7905629
    [Abstract] [Full Text] [Related]

  • 18. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.
    Singleton TP, Strickler JG.
    Pathol Annu; 1992 Nov 01; 27 Pt 1():165-90. PubMed ID: 1346551
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.